Laddar...
Exposure to wild-type AAV drives distinct capsid immunity profiles in humans
Recombinant adeno-associated virus (AAV) vectors have been broadly adopted as a gene delivery tool in clinical trials, owing to their high efficiency of transduction of several host tissues and their low immunogenicity. However, a considerable proportion of the population is naturally exposed to the...
Sparad:
| I publikationen: | J Clin Invest |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
American Society for Clinical Investigation
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6264647/ https://ncbi.nlm.nih.gov/pubmed/30352429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI122372 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|